Your browser doesn't support javascript.
loading
Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing.
Yamamoto, Yoshihiro; Kanai, Masashi; Kou, Tadayuki; Sugiyama, Aiko; Nakamura, Eijiro; Miyake, Hidehiko; Yamada, Takahiro; Nishigaki, Masakazu; Kondo, Tomohiro; Murakami, Hiromi; Torishima, Masako; Matsumoto, Shigemi; Kosugi, Shinji; Muto, Manabu.
Afiliação
  • Yamamoto Y; Department of Medical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kanai M; Department of Medical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. kanai@kuhp.kyoto-u.ac.jp.
  • Kou T; Department of Medical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sugiyama A; DSK Project, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nakamura E; DSK Project, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Miyake H; Faculty of Core Research, Natural Science Division, Ochanomizu University, Tokyo, Japan.
  • Yamada T; Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan.
  • Nishigaki M; Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan.
  • Kondo T; Department of Medical Ethics and Medical Genetics, Kyoto University School of Public Health, Kyoto, Japan.
  • Murakami H; Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan.
  • Torishima M; Department of Human Health Sciences, School of Medicine, Kyoto University, Kyoto, Japan.
  • Matsumoto S; Department of Medical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kosugi S; Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan.
  • Muto M; Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan.
J Hum Genet ; 65(2): 125-132, 2020 Jan.
Article em En | MEDLINE | ID: mdl-31628423

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Genética / Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Proteína BRCA1 / Proteína BRCA2 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Genética / Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Proteína BRCA1 / Proteína BRCA2 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article